跳至主要内容
临床试验/NCT02493933
NCT02493933Unknown1 期

Phytoestrogen, NO Donors, N-acetyl Cysteine Add Therapy to Clomiphene

Kasr El Aini Hospital0 个研究点目标入组 240 人开始时间: 2015年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
发起方
入组人数
240
主要终点
clinical pregnancy rate

研究概览

简要总结

To evaluate the effect of oral Phytoestrogen or Isosorbid mononitrate or N-acetyl cysteine as an adjuvant to clomiphene citrate on induction of ovulation and pregnancy outcomes in patients with PCOS. In this three-arm open RCT, 240 PCOS infertile women were randomly divided to 3 groups for induction of ovulation. Group A, [PE group, n= 80] patients received CC 100mg/d plus oral Phytoestrogen120 mg/ day and patients in Group B, [ISMN group, n=80] received CC 100 mg/d plus 20 mg Isosorbid mononitrate and Group C, [NAC group, n=80] patients received CC 100 mg/d plus NAC 1200 mg/day.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • All patients have PCOS.
  • All patients received CC 100 mg/day for 5 days starting from day 5 with successful ovulation as documented by folliculometry and midluteal serum progesterone with no pregnancy achieved.
  • All patients have patent fallopian tubes by Hysterosalpingography.
  • Their husbands have normal semen analysis according to the modified criteria of WHO.
  • All patients have normal serum prolactin and thyroid profile.
  • Any patient having vaginitis was treated before starting induction.

排除标准

  • Other causes of infertility than anovulation.
  • Diabetes or other endocrinological disorders.
  • Age > 40 years.
  • Alcohol use.
  • Presence of ovarian cyst >2cm on the second day of the cycle.
  • Patients who have received gonadotrophins in the preceeding 6 months.
  • Patients who have done unilateral or bilateral ovarian drilling.
  • Allergy to PE, NO donors or NAC

研究组 & 干预措施

Phytoestrogen

Active Comparator

Patients received oral PE 120 mg/ day in the form of dry coated tablets (Klimadynon, Bionorica, Germany) 2 tablets three times daily from day 1 to day 12 as adjuvant to CC in the follicular phase of the cycle.

干预措施: Phytoestrogens, Isosorbid mononitrate, N-acetyl cysteine (Drug)

Isosorbid mononitrate

Active Comparator

Patients received in addition to CC 20 mg Isosorbid mononitrate (ISMN) tablet (EFFOX, Minapharm Co., Egypt under licence of Shwartz pharma,Germany) applied vaginally from day 1 to day 12 of the cycle.

干预措施: Phytoestrogens, Isosorbid mononitrate, N-acetyl cysteine (Drug)

N-Acetyl cysteine

Active Comparator

Patients received supplementation to CC with NAC 1200 mg/day orally (N-acetyl cysteine, Sedico, Cairo, ARE) sachets 200 mg each, as two sachets thrice daily from day 1 to day 12 of the cycle.

干预措施: Phytoestrogens, Isosorbid mononitrate, N-acetyl cysteine (Drug)

结局指标

主要结局

clinical pregnancy rate

时间窗: 6 months

次要结局

未报告次要终点

研究者

发起方
Kasr El Aini Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Nawara Mohamed Hashish

Assistant professor

Kasr El Aini Hospital

相似试验